EQUITY RESEARCH MEMO

PathKeeper Surgical

Generated 5/24/2026

Executive Summary

Conviction (model self-assessment)70/100

PathKeeper Surgical is an Israeli medical device company pioneering AI-driven 3D optical navigation for spine surgery. Its flagship PathKeeper Full Spine Navigation System offers real-time, radiation-free guidance with submillimeter accuracy, aimed at reducing screw placement errors and eliminating intraoperative radiation exposure—addressing key pain points in spinal procedures. Founded in 2018 and currently in the commercial stage with 10–50 employees, the company is positioned to capture a significant share of the growing global spine surgery market, which is increasingly adopting minimally invasive and navigation-assisted techniques. While the technology demonstrates strong differentiation, the company faces entrenched competition from established players like Medtronic and NuVasive, as well as regulatory hurdles in key markets. Nevertheless, early commercial traction and a robust innovation pipeline position PathKeeper for potential growth, especially if it secures broad regulatory approvals and clinical validation.

Upcoming Catalysts (preview)

  • Q3 2026FDA 510(k) Clearance for U.S. Market Entry70% success
  • H1 2026Publication of Positive Clinical Outcomes80% success
  • H2 2026Strategic Partnership or Distribution Agreement with Major Orthopedic Player60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)